Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Aminoglycoside; protein translation inhibitor, ...
Binds to neurotoxin receptor site 2 on voltage-...
V600E B-Raf inhibitor.
Aldehyde dehydrogenase, 26S proteasome, MGMT in...
Inhibitor of T-lymphokine-activated killer cell...
Diterpene antibiotic produced by Cephalosporum;...
Thiazolidinedione; PPARγ agonist, ATP-sensitiv...
B-Raf and c-Raf inhibitor.
Carcinoembryonic antigen epitope.
EGFR (WT, T790M) inhibitor.
Caffeic acid derivative.
Endogenous peptide hormone; GnRH agonist.
Anthracycline, DNA intercalator; topoisomerase ...
mAChR antaonist.
Inhibitor of TRK.
β-lactam cephalosporin; penicillin binding pro...
Nucleoside (thymidine) analog.
Derivative of camptothecin.
Camptothecin derivative; topoisomerase I inhibi...
Cannabinoid receptor 2 selective agonist.